Health Media ArticlesExcerpts of Key Health Media Articles in Major Media
Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
EpiPen prices aren't the only thing to jump at Mylan. Executive salaries have also seen a stratospheric uptick. Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch's total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase. In 2007 the company bought the rights to EpiPen, a device used to provide emergency epinephrine to stop a potentially fatal allergic reaction and began raising its price. In 2008 and 2009, Mylan raised the price by 5 percent. At the end of 2009 it tried out a 19 percent hike. The years 2010-2013 saw a succession of 10 percent price hikes. And from the fourth quarter of 2013 to the second quarter of 2016, Mylan steadily raised EpiPen prices 15 percent every other quarter. After Mylan acquired EpiPen the company also amped up its lobbying efforts. In 2008, its reported spending on lobbying went from $270,000 to $1.2 million, according to opensecrets.org. Legislation that enhanced its bottom line followed, with the FDA changing its recommendations in 2010 that two EpiPens be sold in a package instead of one. And in 2013 the government passed a law to give block grants to states that required they be stocked in public schools.
When it comes to women’s progress, the United States doesn’t exactly bring home the gold. We rank 72nd in women’s political participation, with women holding less than 20% of congressional seats. Paid maternity leave? The United States comes in last. But at long last, we’re number one at something: Texas has the highest maternal mortality rate in the developed world. The rate of women dying from pregnancy complications doubled from 2010-2014. It’s not a coincidence, of course, that there was another major happening around women’s health in Texas during those years: the deliberate closure of clinics that provide abortion and a drastic funding cut to the state’s family planning budget. Texas gutted the state’s family planning budget by more than $73m in 2011, forcing clinics to shut down and dramatically reducing the number of women they could provide services to. By 2014, 600 women had died from pregnancy-related complications. It’s almost as if what feminists have been saying for years is true: limiting reproductive rights hurts women across the board. Access to reproductive care is necessary not just to prevent or end pregnancies, but to ensure healthy outcomes for those who choose to carry their pregnancies to term.
Children exposed to relatively high levels of PCBs in the womb may have an increased risk of developing autism, a new study suggests. PCBs, or polychlorinated biphenyls, are man-made chemicals once used in a wide range of products, from electrical appliances to fluorescent lighting. Use of these chemicals was banned in the 1970s because of concerns about their health effects. But since they do not easily break down, PCBs still linger in the environment - and in people. In the new study, researchers found that when pregnant women had relatively high levels of certain PCBs in their blood, their children were about 80 percent more likely to be diagnosed with autism versus other kids. Those children also had a roughly twofold higher risk of intellectual disabilities unrelated to autism. "Autism is a complex condition with many different causes, and those causes vary among individuals," said Kristen Lyall, lead researcher on the study. Experts believe that for children to develop autism, they have to have a genetic susceptibility and be exposed to certain environmental factors during critical periods of early brain development. Researchers are still trying to figure out what those environmental factors are. But some suspects include prenatal exposure to poor nutrition, certain infections, heavy air pollution and pesticides, according to the non-profit Autism Speaks. The new findings suggest that PCBs could be another one of the "puzzle pieces," said Lyall.
Note: Monsanto and other chemical manufacturers spent decades dumping PCBs in low-income areas. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health.
The Florida Keys are three months away from a straw poll vote on whether to release millions of genetically modified mosquitoes on an island just east of Key West. The tourist destination is awash in lawn signs ... that showcase the overhead view of a mosquito and read: “NO CONSENT to release of genetically modified mosquitoes”. For the last five years, the biotechnology company Oxitec has been developing a plan to experimentally release the GMO mosquitoes in the Keys, which scientists hope could eventually impede the spread of the Zika virus [by undercutting] the population of Aedes aegypti mosquitoes. But the prospect of ridding the neighborhood of a disease-carrying pest hasn’t quelled public dissatisfaction. Mila de Mier ... has led the charge against the mosquitoes’ release, collecting nearly 170,000 signatures in an online petition against the experiment. “It’s about human rights – this can’t be pushed down our throats without consent,” said De Mier. If the trial goes well, the technology would be on track to commercial approval in the United States, opening a slice of the nation’s $14bn pest control market to the company. Globally, analysts predict Oxitec’s mosquito could bring in up to $400m in annual sales for its parent company, Intrexon. With millions in potential sales at stake, the experiment in the environmentally sensitive, populous area hinges on the fundamental question proposed by opponents: do the people who live where an experiment is to be conducted have a right to decide whether to go forward?
Note: Oxitec, a company criticized for secretly releasing GM mosquitoes into the wild in 2009, was purchased last August by biotech giant Intrexon for $160 million. By December, the Zika virus was all over the news and Intrexon was ramping up production of these GM insects to "fight Zika" in Brazil. For more along these lines, see concise summaries of deeply revealing news articles on GMO controversies and Zika virus fear mongering.
Despite having one of the world's most advanced economies, the United States lags far behind other countries in its policies for expectant mothers. In addition to being the only highly competitive country where mothers are not guaranteed paid leave, it sits in stark contrast to countries such as Cuba and Mongolia that offer expectant mothers one year or more of paid leave. Countries finance paid-maternal-leave policies in a variety of ways. Some require that the employer finance the leave; in others, the money comes from public funds. For low-income residents or those who work in the informal sector, an increasing number of governments are providing maternity cash benefits, according to the International Labor Organization, a U.N.-affiliated agency. From Gambia to Bangladesh, a majority of low- and middle-income countries offer some form of paid leave to mothers. Because current U.S. policy doesn't mandate paid maternity leave, many women feel they have to choose between working and raising a family. This gender inequity undermines their prospects of equal opportunity at work — and, experts say, it disproportionately affects women from lower socioeconomic backgrounds. A 2012 study conducted by the Department of Labor found that, of the workers it polled, 23 percent of women who had left work to care for an infant took less than two weeks off, increasing health risks for both mothers and children.
As part of an ongoing effort to “exploit medical intelligence,” the National Security Agency teamed up with the military-focused Defense Intelligence Agency to extract “medical SIGINT” from the intercepted communications of nonprofit groups starting in the early 2000s, a top-secret document shows. Medical intelligence can include information about disease outbreaks; the ability of a foreign regime to respond to chemical, biological, and nuclear attacks; the capabilities of overseas drugs companies; advances in medical technology; medical research, and the medical response capabilities of various governments, according to the document and others like it, provided by NSA whistleblower Edward Snowden. One of the more prominent examples of focused medical spying came in 2010, when the agency crafted a plan to stow tracking devices with medical supplies bound for an ill Osama bin Laden in order to locate the terrorist leader. One article from August 2003 identifies an NSA project to keep an eye on the evolution of biotechnology in various countries. “Can we ... determine the specific features that would distinguish a Bio Warfare Program from a benign civilian pharmaceutical production effort?” the author wrote, identifying a “suspect Iranian [biological warfare] facility” as a target for inspection. Medical intelligence gathering has continued since then, according to the so-called “black budget” proposed for the 2013 fiscal year, published in February 2012.
Government researchers in Brazil are set to explore the country's peculiar distribution of Zika-linked microcephaly - babies born with abnormally small heads. Zika virus has spread throughout Brazil, but extremely high rates of microcephaly have been reported only in the country's northeast. Although evidence suggests that Zika can cause microcephaly, the clustering pattern hints that other environmental, socio-economic or biological factors could be at play. “We suspect that something more than Zika virus is causing the high intensity and severity of cases,” says Fatima Marinho, director of information and health analysis at Brazil’s ministry of health. If that turns out to be true, it could change researchers' assessment of the risk that Zika poses. Zika was discovered in 1947 and hadn’t been implicated in birth defects until now. The northeast was where the first reported surge in microcephaly cases in Brazil began a year ago. Health officials had expected that they would later see the same high rates in other parts of the country. But as of 20 July, almost 90% of the 1,709 confirmed cases of congenital microcephaly or birth defects of the central nervous system reported in Brazil since last November were in a relatively small area ... about the size of the United Kingdom, whereas Brazil is almost as large as the United States. There are many hypotheses about what might be going on. Marinho says that her team's data, submitted for publication, hint that socio-economic factors might be involved.
Note: The cluster of microcephaly cases in Brazil was reported in February to predate the latest Zika outbreak. For more along these lines, see concise summaries of deeply revealing Zika virus news articles from reliable major media sources.
A safeguard for Medicare beneficiaries has become a way for drugmakers to get paid billions of dollars for pricey medications at taxpayer expense. The cost of Medicare’s “catastrophic” prescription coverage jumped by 85 percent in three years, from $27.7 billion in 2013 to $51.3 billion in 2015. Out of some 2,750 drugs covered by Medicare’s Part D benefit, two pills for hepatitis C infection - Harvoni and Sovaldi - accounted for nearly $7.5 billion in catastrophic drug costs in 2015. Medicare’s catastrophic coverage was originally designed to protect seniors with multiple chronic conditions from the cumulatively high costs of taking many different pills. Beneficiaries pay 5 percent after they have spent $4,850 of their own money. With some drugs now costing more than $1,000 per pill, that threshold can be crossed quickly. Lawmakers who created Part D in 2003 also hoped added protection would entice insurers to participate in the program. Medicare pays 80 percent of the cost of drugs above a catastrophic threshold that combines spending by the beneficiary and the insurer. That means taxpayers, not insurers, bear the exposure for the most expensive patients. Catastrophic spending accounts for a fast-growing share of Medicare’s drug costs, which totaled nearly $137 billion in 2015. The catastrophic share was 37 percent, yet only about 9 percent of beneficiaries reached the threshold for such costs. Catastrophic coverage will soon cost as much as the entire prescription program did when it launched. Experts say the rapid rise in spending for pricey drugs threatens to make the popular prescription benefit financially unsustainable.
Note: Read an excellent essay by former New England Journal of Medicine editor Dr. Marcia Angell exposing The Truth About the Drug Companies. For more along these lines, see concise summaries of deeply revealing Big Pharma profiteering news articles from reliable major media sources.
Dozens of people who were child patients at a psychiatric hospital in the 1960s and 70s claim they were experimented on with a so-called truth serum. "I was your typical 60s teenager," says Marianne. At the age of 14, she [was] sent to Aston Hall, a "mental deficiency hospital". Many claim they were experimented on by the hospital's medical superintendent Dr Kenneth Milner using a drug called sodium amytal. It is known as a "truth serum" for its supposed ability to retrieve ... memories. Former patients ... remember being locked in a small treatment room with a mattress on the floor. Some say their hands were tied with bandages before they were injected. Marianne says she had an internal examination in the room, which was embarrassing and unnecessary, and other patients have alleged sexual abuse by Dr Milner. [She] recalls a session with the doctor where she was stripped, made to wear a stiff white gown and told she would be asked some questions. Then he injected her with a drug that heavily sedated her. "I can remember equating it to being drunk." Her account is similar to those of other former patients at the time, who remember being locked in a small treatment room with a mattress on the floor. Some say their hands were tied with bandages before they were injected. Nearly all the patients we spoke to agreed Dr Milner asked very personal sexual questions during treatment. While former patients search for answers about what really happened to them, they may have to live with the harmful effects of the treatment for the rest of their lives.
Note: For lots more on this, listen to this BBC report. Many people have been used as guinea pigs in government, military, and medical experiments over the last century. For more along these lines, see concise summaries of deeply revealing mind control news articles from reliable major media sources.
Naloxone works by blocking the effect that painkillers and heroin have in the brain and reversing the slowed breathing and unconsciousness that come with an overdose. But as the demand for naloxone has risen - overdose deaths now total 130 every day, or roughly the capacity of a Boeing 737 - the drug’s price has soared. Not long ago, a dose of the decades-old generic drug cost little more than a dollar. Now the lowest available price is nearly 20 times that. In 2014, more than 47,000 Americans died from drug overdoses. That was 50% more deaths than from highway accidents ... and more overdose deaths than any year on record. The overdose crisis has its roots in the 1990s, when doctors began prescribing more and higher doses of painkillers [in response] to campaigns, often funded behind the scenes by drug makers, that urged doctors to prescribe the strongest painkillers not just to cancer patients and others in severe pain, but also to those with milder pain. The narcotic manufacturers’ funding of those campaigns ... came to light through evidence unearthed in lawsuits and investigative journalism reports. Since 1999, the amount of prescription opioids such as oxycodone, morphine and hydrocodone sold in the U.S. nearly quadrupled. During that same time, deaths from those drugs quadrupled. The lethal side effects of that booming prescription painkiller market has now sparked a moneymaking opportunity with naloxone.
Painkiller abuse and overdose are lower in states with medical marijuana laws. When medical marijuana is available, pain patients are increasingly choosing pot over powerful and deadly prescription narcotics. Now a new study [provides] clear evidence of a missing link in the causal chain running from medical marijuana to falling overdoses. Researchers at the University of Georgia scoured the database of all prescription drugs paid for under Medicare Part D from 2010 to 2013. In the 17 states with a medical-marijuana law in place by 2013, prescriptions for painkillers and other classes of drugs fell sharply compared with states that did not have a medical-marijuana law. They found that, in medical-marijuana states, the average doctor prescribed 265 fewer doses of antidepressants each year, 486 fewer doses of seizure medication, 541 fewer anti-nausea doses and 562 fewer doses of anti-anxiety medication. But most strikingly, the typical physician in a medical-marijuana state prescribed 1,826 fewer doses of painkillers in a given year. Estimating the cost savings to Medicare from the decreased prescribing, [the study] found that about $165 million was saved in the 17 medical marijuana states in 2013. The estimated annual Medicare prescription savings would be nearly half a billion dollars if all 50 states were to implement similar programs.
Note: The war on drugs has been called a "trillion dollar failure", and an increasing number of deaths are caused by prescription opioid overdose in the US each year. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
On May 18, a team working at the Walter Reed Army Institute of Research here had its first look at a sample of the bacterium Escherichia coli, taken from a 49-year-old woman in Pennsylvania. Her sample was one of six from across the country delivered to the lab of microbiologist Patrick McGann. Within hours, a preliminary analysis deepened concern at the lab. Over the next several days, more sophisticated genetic sleuthing confirmed McGann’s worst fears. There, in the bacterium’s DNA, was a gene [that] made the pathogen impervious to the venerable antibiotic colistin. More ominously, the gene’s presence ... suggested that it could readily jump to other E. coli bacteria, or to entirely different forms of disease-causing organisms. That would make them impervious to colistin as well. It was a milestone public health officials have been anticipating for years. In a steady march, disease-causing microbes have evolved ways to evade the bulwark of medications used to treat bacterial infections. For a variety of those illnesses, only colistin continued to work every time. Now this last line of defense had been breached as well. Almost as soon as they were given to patients, scientists began finding evidence that disease-causing bacteria were developing resistance to these new wonder drugs. Humans have accelerated this natural process by indiscriminately prescribing antibiotics and by routinely feeding the drugs to livestock.
Note: Millions of unnecessary drug prescriptions and rampant overuse of antibiotics in livestock also produces autoimmune diseases that were virtually unknown to our ancestors. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
It's the time of year when experts crunch the numbers to see how well the flu shot worked. The result? Better than last year, but still not good enough. "Just shy of 45 to 50 per cent," said Dr. Danuta Skowronski of the BC Centre for Disease Control, who presented the data to the Global Influenza Vaccine Effectiveness meeting at the World Health Organization last week. In 2014-15, the flu shot offered essentially zero protection against the circulating influenza virus of that season. Back then, the prevailing strain was H3N2. This year's main circulating virus was H1N1. Skowronski said the vaccine was ... disappointing. Experts used to believe the annual flu shot protection was much higher, around 70 to 90 per cent. But not anymore. Those early estimates were based on industry-funded clinical trials that were extrapolated to apply across all ages and flu seasons. "It was a blanket assumption that is simply not true," Skowronski said. That assumption changed dramatically, after Skowronski and colleagues developed a protocol that revealed the true picture of vaccine efficacy. It's called the test negative design (TND) first piloted in Canada in 2004. "The test negative design has opened our eyes to all kinds of variables that we were blind to for years," said Skowronski. Scientists also once again observed [that] people who get the shot with no prior vaccine exposure seem to have better protection than people who get the shot year after year.
Note: A National Institute of Health study found in 2007 that flu shots do not protect the elderly. More recent studies have shown that some flu shots actually increase the risk of infection. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
Something strange is going on in medicine. Major diseases, like colon cancer, dementia and heart disease, are waning in wealthy countries, and improved diagnosis and treatment cannot fully explain it. Scientists marvel at this good news, a medical mystery of the best sort. The leading killers are still the leading killers - cancer, heart disease, stroke - but they are occurring later in life, and people in general are living longer in good health. Colon cancer is the latest conundrum. While the overall cancer death rate has been declining since the early 1990s, the plunge in colon cancer deaths is especially perplexing: The rate has fallen by nearly 50 percent since its peak in the 1980s. [Dr. Steven R. Cummings of the California Pacific Medical Center Research Institute], intrigued by the waning of disease, has a provocative idea for further investigation. He starts with two observations: Rates of disease after disease are dropping. Even the rate of “all-cause mortality,” which lumps together chronic diseases, is falling. And every one of those diseases at issue is linked to aging. Perhaps, he said, all these degenerative diseases share something in common, something inside aging cells themselves. The cellular process of aging may be changing, in humans’ favor. For too long, he said, researchers have looked under the lamppost at things they can measure. “I want to look inside cells,” Dr. Cummings said. Inside, there could be more clues to this happy mystery.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
As a physician, I have encountered many people who believe that heart disease, which is the single biggest cause of death among Americans, is largely controllable. After all, if people ate better, were physically active and stopped smoking, then lots of them would get better. This ignores the fact that people can’t change many risk factors of heart disease like age, race and family genetics. People don’t often seem to feel the same way about cancer. They think it’s out of their control. A ... recent study published in Nature argues that there is a lot we can do. Many studies have shown that environmental risk factors and exposures contribute greatly to many cancers. Diet is related to colorectal cancer. Alcohol and tobacco are related to esophageal cancer. HPV is related to cervical cancer, and hepatitis C is related to liver cancer. And you’d have to be living under a rock not to know that smoking causes lung cancer and that too much sun can lead to skin cancer. Using sophisticated modeling techniques, the researchers argued that less than 30 percent of the lifetime risk of getting many common cancers was because of intrinsic risk factors, or the “bad luck.” The rest were things you can change. [More] recently, in JAMA Oncology, researchers sought to quantify how a healthful lifestyle might actually alter the risk of cancer. They [found that] about 25 percent of cancer in women and 33 percent in men was potentially preventable.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Thousands of dogs across Britain are dying or suffering severe allergic reactions after being treated with a vaccine meant to protect them against mild bacterial infections. Fears over the safety of the vaccine against leptospirosis - a bacterial infection spread to dogs through rats and wild animals – have now led veterinary organisations to issue warnings about its side effects. The World Small Animal Veterinary Association (WSAVA) is urging owners not to use Nobivac L4 vaccine on puppies under 12 weeks old. However, [it] is still being administered in veterinary practices across Britain to dogs from seven weeks old, with little warning of the potential side effects. According to reports made to the Government's Veterinary Medicines Directorate (VMD) by pet owners, more than 120 dogs are feared to have died after receiving a dosage in the three years the product has been on the market. In the last two years, regulators have received 2,000 reports of dogs having suspected adverse or fatal reactions. Owners that have opted for the L4 vaccine ... have reported adverse effects including epileptic fits, swollen glands and blindness. The vaccine, which is manufactured by MSD Animal Health, a subsidiary of American conglomerate Merck Sharp & Dohme, is currently being monitored by the VMD. The regulator has however refused to reveal the total number of animals that had been affected since the product came onto the market, prompting concern among dog owners that the scale of problem is being kept hidden from the public.
Note: For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.
Nearly all food labels in Vermont are now required to disclose when products include genetically engineered ingredients. The requirement, passed two years ago, became effective on Friday. The rule is the first of its kind in the United States, and although it applies only within the tiny state, it is having national impact. Most major food and beverage companies have already added language to their labels to meet the new rule, rather than deal with the logistical hassle of having separate labels for different states. But not all the same products will definitely be on shelves. Vermont’s law requires the labeling of most packaged grocery products as well as any whole fruits or vegetables produced with genetic engineering. That means virtually all products containing derivatives of crops like corn, soy, canola and sugar from sugar beets will need labels, as most of those crops in the United States are grown from genetically modified seeds. Vermont’s law is careful, however, to exclude cheese, a big business in the state. The law also exempts meat from animals that have eaten feed made from genetically engineered grains. The labeling issue has generated heavy and frantic lobbying by the Grocery Manufacturers Association and the trade groups representing major commodity producers of crops like soy and corn, who have wanted a federal law that would prevent mandatory labels.
Note: On July 8, the US Senate passed a bill which allows food companies to continue to avoid clear GMO ingredient labeling. Let's hope it does not pass the full Congress and become a law. For more along these lines, see concise summaries of deeply revealing food industry corruption and GMO news articles from reliable major media sources.
Lisa Alamia had the jaw surgery in December. She underwent the procedure to correct a serious overbite, and it was a success, according to Houston Methodist Sugar Land Hospital. The 33-year-old woke up and had minimal swelling. But then she began to talk. The voice coming out of Alamia’s mouth didn’t sound like it belonged to a Houston-area native. It sounded British. “My daughter laughs at the way I say ‘tamales.’ I used to be able to say it like a real Hispanic girl,” Alamia told KHOU. “Now, I cannot.” Months later, she still speaks as if she’s from across the pond. Eventually, she saw neurologist Toby Yaltho at Houston Methodist Sugar Land Neurology Associates, who diagnosed her with a very rare condition: Foreign Accent Syndrome, or FAS. The rare speech disorder was first described in 1907 by French neurologist Pierre Marie, and since then, there have been only about 100 documented cases. A person with FAS has an accent considered by the patient, others and doctors to sound “foreign” and unlike the patient’s previous dialect. Previous exposure to such an accent isn’t necessary. FAS usually follows stroke, while it’s also been diagnosed following traumatic brain injury, cerebral hemorrhage and multiple sclerosis. Only a few cases seem to have psychological origins. The cause of Alamia’s FAS remains a mystery. “Everything came back normal,” Yaltho said in a release. “There was no evidence of stroke or other abnormalities.”
Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
The American Medical Association (AMA) has just adopted an official policy statement about street lighting: cool it and dim it. The statement, adopted unanimously at the AMA's annual meeting ... comes in response to the rise of new LED street lighting sweeping the country. Municipalities are replacing existing streetlights with efficient and long-lasting LEDs to save money on energy and maintenance. Although the streetlights are delivering these benefits, the AMA's stance reflects ... the close connection between light and human health. The new "white" LED street lighting ... has two problems. The first is discomfort and glare. Because LED light is so concentrated and has high blue content, it can cause severe glare ... and sufficient levels can damage the retina. This can cause problems seeing clearly for safe driving or walking at night. The other issue addressed by the AMA statement is the impact on human circadian rhythmicity. Lighting affects our normal circadian physiology. This could lead to some serious health consequences. White LED light ... is estimated to be five times more effective at suppressing melatonin at night than the high pressure sodium lamps (given the same light output) which have been the mainstay of street lighting for decades. Melatonin suppression is a marker of circadian disruption, which includes disrupted sleep. The AMA "encourage[s] minimizing and controlling blue-rich environmental lighting by using the lowest emission of blue light possible to reduce glare." All LED lighting should be properly shielded.
Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.
Physician influence can be bought for as little as a $20 meal, UCSF researchers have found. A study published Monday in JAMA Internal Medicine ... found that doctors who received just one meal averaging $20 were up to twice as likely to prescribe brand-name drugs being promoted than doctors who did not receive any free food. Gifts from pharmaceutical companies to doctors ... have come under scrutiny in recent years for concerns that the money spent by drugmakers directly influences what physicians write on their prescriptions pads. Some doctors deny they’re influenced by money, but a growing number of studies show that financial ties can affect their professional behavior. The UCSF researchers looked at ... the routine briefings many doctors and their staff receive from drug reps during lunches in their offices. The study found that the effect increased as doctors got more meals. Those who received multiple meals were up to three times as likely to prescribe the promoted brand-name drug. Higher-cost meals were associated with greater influence. Doctors who received four or more meals to promote Allergan’s Bystolic to treat hypertension prescribed the drug at 5.4 times the rate of physicians who received no meals. For Pfizer’s depression drug Pristiq, that rate was 3.4 times higher. UCSF researchers said that their studies show the buying power of drug makers decreases the use of cheaper, generic drugs and raises costs for patients as well as the health care system.
Note: For more along these lines, see concise summaries of deeply revealing big Pharma profiteering news articles from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.